Advertisement
Screener

Myovant Sciences Ltd. Selling, General and Administrative Expense

Myovant Sciences Ltd. Selling, General and Administrative Expense

Myovant Sciences Ltd. reported Selling, General and Administrative Expense of $86.38 million for the 3-month period ending 2022-12-31, per its 10-Q filed 2023-01-26.

Discontinued › Expense Statement › Operating Expenses

us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2023-01-26

  • Myovant Sciences Ltd. selling, general and administrative expense for the quarter ending 2022-12-31 was $86.38M, a 19.76% increase year-over-year.
  • Myovant Sciences Ltd. selling, general and administrative expense for the quarter ending 2022-09-30 was $84.26M, a 43.34% increase year-over-year.
  • Myovant Sciences Ltd. selling, general and administrative expense for the quarter ending 2022-06-30 was $79.03M, a 29.11% increase year-over-year.
  • Myovant Sciences Ltd. selling, general and administrative expense for the quarter ending 2022-03-31 was $67.25M, a 13.83% decline year-over-year.
  • Myovant Sciences Ltd. selling, general and administrative expense for fiscal 2022 was $259.36M, a 42.96% increase from fiscal 2021.
  • Myovant Sciences Ltd. selling, general and administrative expense for fiscal 2021 was $181.42M, a 120.37% increase from fiscal 2020.
  • Myovant Sciences Ltd. selling, general and administrative expense for fiscal 2020 was $82.33M, a 95.00% increase from fiscal 2019.
  • Myovant Sciences Ltd. selling, general and administrative expense for fiscal 2019 was $42.22M.
Period endSelling, General and Administrative Expense 3 monthSelling, General and Administrative Expense 6 monthSelling, General and Administrative Expense 9 monthSelling, General and Administrative Expense 12 month
2022-12-31$86.38M
10-Q · filed 2023-01-26
$170.64M
derived: sum of 2 quarters · filed 2023-01-26
$249.67M
10-Q · filed 2023-01-26
$316.92M
derived: sum of 4 quarters · filed 2023-01-26
2022-09-30$84.26M
10-Q · filed 2022-10-26
$163.29M
10-Q · filed 2022-10-26
$230.54M
derived: sum of 3 quarters · filed 2022-10-26
$302.66M
derived: sum of 4 quarters · filed 2023-01-26
2022-06-30$79.03M
10-Q · filed 2022-07-27
$146.28M
derived: sum of 2 quarters · filed 2022-07-27
$218.40M
derived: sum of 3 quarters · filed 2023-01-26
$277.18M
derived: sum of 4 quarters · filed 2023-01-26
2022-03-31$67.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-11
$139.37M
derived: sum of 2 quarters · filed 2023-01-26
$198.15M
derived: sum of 3 quarters · filed 2023-01-26
$259.36M
10-K · filed 2022-05-11
2021-12-31$72.13M
10-Q · filed 2023-01-26
$130.91M
derived: sum of 2 quarters · filed 2023-01-26
$192.12M
10-Q · filed 2023-01-26
$270.15M
derived: sum of 4 quarters · filed 2023-01-26
2021-09-30$58.78M
10-Q · filed 2022-10-26
$119.99M
10-Q · filed 2022-10-26
$198.03M
derived: sum of 3 quarters · filed 2022-10-26
$247.27M
derived: sum of 4 quarters · filed 2022-10-26
2021-06-30$61.21M
10-Q · filed 2022-07-27
$139.25M
derived: sum of 2 quarters · filed 2022-07-27
$188.49M
derived: sum of 3 quarters · filed 2022-07-27
$219.81M
derived: sum of 4 quarters · filed 2022-07-27
2021-03-31$78.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-11
$127.28M
derived: sum of 2 quarters · filed 2022-05-11
$158.59M
derived: sum of 3 quarters · filed 2022-05-11
$181.42M
10-K · filed 2022-05-11
2020-12-31$49.24M
10-Q · filed 2022-01-26
$80.56M
derived: sum of 2 quarters · filed 2022-01-26
$103.39M
10-Q · filed 2022-01-26
$125.82M
derived: sum of 4 quarters · filed 2022-05-11
2020-09-30$31.32M
10-Q · filed 2021-10-26
$54.14M
10-Q · filed 2021-10-26
$76.57M
derived: sum of 3 quarters · filed 2022-05-11
$105.72M
derived: sum of 4 quarters · filed 2022-05-11
2020-06-30$22.83M
10-Q · filed 2021-07-28
$45.26M
derived: sum of 2 quarters · filed 2022-05-11
$74.40M
derived: sum of 3 quarters · filed 2022-05-11
2020-03-31$22.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-11
$51.57M
derived: sum of 2 quarters · filed 2022-05-11
$82.33M
10-K · filed 2022-05-11
2019-12-31$29.14M
10-Q · filed 2021-02-11
$59.90M
10-Q · filed 2021-02-11
2019-03-31$42.22M
10-K · filed 2021-05-11